An exploratory prospective phase II study of preoperative neoadjuvant bevacizumab and temozolomide for newly diagnosed glioblastoma.
Tanaka T, Tamura R, Takei J, Morimoto Y, Teshigawara A, Yamamoto Y, Imai R, Kuranari Y, Tohmoto K, Hasegawa Y, Akasaki Y, Murayama Y, Miyake K, Sasaki H.
Tanaka T, et al.
J Neurooncol. 2024 Feb;166(3):557-567. doi: 10.1007/s11060-023-04544-8. Epub 2024 Jan 31.
J Neurooncol. 2024.
PMID: 38291182
Free PMC article.
Clinical Trial.